dopexamine has been researched along with Chronic Illness in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, L; Sjögren, A; Svensson, G | 1 |
| Hampton, JR; Murphy, JJ | 1 |
| Baumann, G; Gutting, M; Klein, G; Ningel, K; Pfafferott, C | 1 |
| Chatterjee, K; De Marco, T; Kwasman, M; Lau, D | 1 |
1 trial(s) available for dopexamine and Chronic Illness
| Article | Year |
|---|---|
Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Chronic Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Ferricyanides; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Random Allocation; Stimulation, Chemical | 1988 |
3 other study(ies) available for dopexamine and Chronic Illness
| Article | Year |
|---|---|
Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failure.
Topics: Adrenergic Agonists; Adult; Aged; Chronic Disease; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1986 |
Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.
Topics: Adrenergic Agonists; Aged; Chronic Disease; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged | 1988 |
Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost.
Topics: Adult; Aged; Chronic Disease; Coronary Circulation; Dopamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Norepinephrine | 1988 |